Skip to content
Home / Companies / PSNL PSN
Personalis, Inc. (PSNL) XNAS SERVICES-MEDICAL LABORATORIES Net insider selling (90d)
Latest PSNL Insider Trades
About Personalis, Inc. (PSNL) Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Headquarters FREMONT, CA
Employees 260
Listed 2019
Exchange XNAS https://www.personalis.com SEC filings for PSNL on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 6 396,233 $5.56M Grant or award 1 6,250 Option exercise 15 792,466
PSNL Insider Transactions (Form 4) 77 40 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Jul 15, 2026 RC Richard Chen - Officer Option exercise Common Stock 100,000
Recent PSNL Form 8-K Filings 5
Recent PSNL Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jul 15, 2026 - - - - View on EDGAR Jul 9, 2026 - - -
PSNL Insider Trading - FAQ
What is the latest insider trade for PSNL? Personalis, Inc. (PSNL) had 7 insider filings in the last 90 days, with the most recent on 2026-07-16. The full record for PSNL runs to 40 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PSNL stock? No insider purchases of PSNL were filed in the last 90 days. 12 purchases are on record for this company.
How many insiders are selling PSNL stock? 6 insider sales of PSNL were filed in the last 90 days, totaling $5.56M.
Where can I see PSNL SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks PSNL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PSNL insider buys? Create a free InsiderAlpha account and press Watch on this page to add PSNL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track PSNL insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $1.82B
P/E ratio -
Dividend yield -
Average volume 4.19M
52 week high $18.89
52 week low $4.65
Today's high $17.24
Today's low $16.60
Open $16.75
Volume 2.97M
Previous close $16.80
Shares outstanding 106.80M Market cap
$1.82B
260 employees
PSNL Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 6 sales totaling $5.56M.
Most-Active PSNL Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jul 15, 2026 RC Richard Chen - Officer Open-market sale Common Stock 100,000 $15.15 $1.51M
Jul 15, 2026 RC Richard Chen - Officer Option exercise Stock Option (right to buy) 100,000 $0.00 -
Jul 9, 2026 CH Christopher M. Hall - Officer Option exercise Stock Option (right to buy) 66,667 $0.00 -
Jul 9, 2026 CH Christopher M. Hall - Officer Option exercise Stock Option (right to buy) 33,333 $0.00 -
Jun 29, 2026 AT Aaron Tachibana - Officer Option exercise Common Stock 4,982 $5.32 $27K
Jun 29, 2026 AT Aaron Tachibana - Officer Open-market sale Common Stock 4,982 $14.00 $70K
Jun 29, 2026 AT Aaron Tachibana - Officer Option exercise Stock Option (right to buy) 4,982 $0.00 -
Jun 26, 2026 AT Aaron Tachibana - Officer Option exercise Common Stock 22,419 $5.32 $119K
Jun 26, 2026 AT Aaron Tachibana - Officer Open-market sale Common Stock 51,251 $13.18 $675K
Jun 26, 2026 AT Aaron Tachibana - Officer Option exercise Stock Option (right to buy) 28,832 $0.00 -
Jun 26, 2026 AT Aaron Tachibana - Officer Option exercise Stock Option (right to buy) 22,419 $0.00 -
Jun 26, 2026 AT Aaron Tachibana - Officer Option exercise Common Stock 28,832 $9.16 $264K
Jun 26, 2026 CH Christopher M. Hall - Officer Option exercise Stock Option (right to buy) 100,000 $0.00 -
Jun 4, 2026 AT Aaron Tachibana - Officer Option exercise Common Stock 40,000 $9.16 $366K
Jun 4, 2026 AT Aaron Tachibana - Officer Open-market sale Common Stock 40,000 $12.01 $480K
Jun 4, 2026 AT Aaron Tachibana - Officer Option exercise Stock Option (right to buy) 40,000 $0.00 -
May 28, 2026 CH Christopher M. Hall - Officer Option exercise Stock Option (right to buy) 19,909 $0.00 -
May 29, 2026 CH Christopher M. Hall - Officer Option exercise Stock Option (right to buy) 80,091 $0.00 -
May 29, 2026 AT Aaron Tachibana - Officer Option exercise Common Stock 38,799 $9.16 $355K
May 29, 2026 AT Aaron Tachibana - Officer Open-market sale Common Stock 38,799 $11.58 $449K
May 29, 2026 AT Aaron Tachibana - Officer Option exercise Stock Option (right to buy) 38,799 $0.00 -
May 12, 2026 KE Karin Eastham Grant or award Stock Option (right to buy) 37,500 $0.00 -
May 12, 2026 AB A. Blaine Bowman Grant or award Stock Option (right to buy) 37,500 $0.00 -
May 12, 2026 LS Lonnie Shoff Grant or award Common Stock 6,250 $0.00 -
May 12, 2026 LS Lonnie Shoff Grant or award Stock Option (right to buy) 37,500 $0.00 -
Mar 15, 2026 AT Aaron Tachibana - Officer Grant or award Stock Option (right to buy) 206,250 $0.00 -
Mar 15, 2026 AT Aaron Tachibana - Officer Grant or award Common Stock 34,375 $0.00 -
Mar 15, 2026 CH Christopher M. Hall - Officer Grant or award Stock Option (right to buy) 525,000 $0.00 -
Mar 15, 2026 RC Richard Chen - Officer Grant or award Common Stock 46,875 $0.00 -
Mar 15, 2026 RC Richard Chen - Officer Grant or award Stock Option (right to buy) 281,250 $0.00 -
Feb 23, 2026 AT Aaron Tachibana - Officer Grant or award Stock Option (right to buy) 15,000 $0.00 -
Feb 23, 2026 RC Richard Chen - Officer Grant or award Stock Option (right to buy) 15,000 $0.00 -
Feb 23, 2026 CH Christopher M. Hall - Officer Grant or award Stock Option (right to buy) 33,333 $0.00 -
Nov 18, 2025 Tempus AI, Inc. Open-market purchase Common Stock 64,750 $7.67 $497K
Nov 19, 2025 Tempus AI, Inc. Open-market purchase Common Stock 30,645 $8.12 $249K
Nov 20, 2025 Tempus AI, Inc. Open-market purchase Common Stock 28,827 $8.63 $249K
Nov 21, 2025 Tempus AI, Inc. Open-market purchase Common Stock 16,599 $9.74 $162K
Nov 24, 2025 Tempus AI, Inc. Open-market purchase Common Stock 25,225 $9.87 $249K
Nov 25, 2025 Tempus AI, Inc. Open-market purchase Common Stock 13,888 $11.00 $153K
Dec 17, 2025 Tempus AI, Inc. Open-market purchase Common Stock 31,650 $7.86 $249K
Dec 18, 2025 Tempus AI, Inc. Open-market purchase Common Stock 31,430 $7.91 $249K
Dec 19, 2025 Tempus AI, Inc. Open-market purchase Common Stock 29,641 $8.39 $249K
Dec 22, 2025 Tempus AI, Inc. Open-market purchase Common Stock 28,000 $8.93 $250K
Jan 22, 2026 AT Aaron Tachibana - Officer Option exercise Common Stock 1,201 $9.16 $11K
Jan 22, 2026 AT Aaron Tachibana - Officer Open-market sale Common Stock 1,201 $11.50 $14K
Jan 22, 2026 AT Aaron Tachibana - Officer Option exercise Stock Option (right to buy) 1,201 $0.00 -
Nov 25, 2025 AT Aaron Tachibana - Officer Option exercise Common Stock 103,668 $9.16 $950K
Nov 25, 2025 AT Aaron Tachibana - Officer Open-market sale Common Stock 103,668 $10.78 $1.12M
Nov 25, 2025 AT Aaron Tachibana - Officer Option exercise Stock Option (right to buy) 103,668 $0.00 -
Jul 28, 2025 RC Richard Chen - Officer Open-market sale Common Stock 452 $6.57 $3K
Jul 28, 2025 AT Aaron Tachibana - Officer Open-market sale Common Stock 641 $6.57 $4K
PYX $VCYT
VERACYTE, INC.
